Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug ConjugateNicole M. Okeley, Stephen C. Alley, Eric L. Sievers et al.|Clinical Cancer Research|2010Cited by 386
A Potent Anti-CD70 Antibody–Drug Conjugate Combining a Dimeric Pyrrolobenzodiazepine Drug with Site-Specific Conjugation TechnologyScott C. Jeffrey, Peter D. Senter, Django Sussman et al.|Bioconjugate Chemistry|2013Cited by 246